|
1）Sugimori C, Chuhjo T, Feng X, et al. Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood. 2006; 107: 1308-14
|
|
|
|
2）Katagiri T, Sato-Otsubo A, Kashiwase K, et al. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia. Blood. 2011; 118: 6601-9
|
|
|
|
|
|
3）Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4＋ T cells expressing the FoxP3 transcription factor. Immunity. 2009; 30: 899-911
|
|
|
|
|
|
4）Kordasti S, Marsh J, Al-Khan S, et al. Functional characterization of CD4＋ T cells in aplastic anemia. Blood. 2012; 119: 2033-43
|
|
|
|
|
|
5）Solomou EE1, Rezvani K, Mielke S, et al. Deficient CD4＋ CD25＋ FOXP3＋ T regulatory cells in acquired aplastic anemia. Blood. 2007; 110: 1603-6
|
|
|
|
|
|
6）Zoumbos NC, Gascon P, Djeu JY, et al. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A. 1985; 82: 188-92
|
|
|
|
|
|
7）Schultz JC, Shahidi NT. Detection of tumor necrosis factor-alpha in bone marrow plasma and peripheral blood plasma from patients with aplastic anemia. Am J Hematol. 1994; 45: 32-8
|
|
|
|
|
|
8）Nakao S, Yamaguchi M, Shiobara S, et al. Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia. Blood. 1992; 79: 2532-5
|
|
|
|
|
|
9）de Latour RP1, Visconte V, Takaku T, et al. Th17 immune responses contribute to the pathophysiology of aplastic anemia. Blood. 2010; 116: 4175-84
|
|
|
|
|
|
10）Feng X, Kajigaya S, Solomou EE, et al. Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro. Blood. 2008; 111: 3675-83
|
|
|
|
|
|
11）Scheinberg P, Nunez O, Weinstein B, et al. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med. 2011; 365: 430-8
|
|
|
|
|
|
12）Shi J, Ge M, Lu S, et al. Intrinsic impairment of CD4(+)CD25(+) regulatory T cells in acquired aplastic anemia. Blood. 2012; 120: 1624-32
|
|
|
|
|
|
13）Desmond R, Townsley DM, Dumitriu B, et al. Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood. 2014; 123: 1818-25
|
|
|
|
|